A Pharmacodynamic and Pharmacokinetic Study of CM4620 Injectable Emulsion (CM4620-IE) in Patients With Acute Pancreatitis
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2019
Price : $35 *
At a glance
- Drugs CM 4620 (Primary)
- Indications Pancreatitis
- Focus Therapeutic Use
- Sponsors CalciMedica
- 07 Nov 2019 Results published in the CalciMedicaMedia Release.
- 07 Nov 2019 According to an CalciMedica media release, Dr. Joseph Miller is the principal investigator for this study.
- 07 Nov 2019 According to an CalciMedica media release, this study will be presented as a poster at the American Pancreas Association annual meeting.